Newsweek has contacted Moderna and the HHS via email outside of regular office hours. Avian influenza A (H5N1) has caused at least 67 human illnesses, and was associated with one death ...
Moderna is already making preparations to launch a phase 3 study of mRNA-1018, a vaccine against H5 and H7 avian influenza viruses. The mRNA-1018 vaccine has produced “positive preliminary data ...
“Avian flu variants have proven to be particularly ... ensure that Americans have the tools they need to stay safe.” A Moderna spokesperson told MassLive the company is preparing to advance ...
Since 2021, experts have seen bird flu — also called H5 influenza or highly pathogenic avian influenza (HPAI) — spreading "fairly quickly" across the wild and domestic bird populations and, now, among ...
In 2023, Moderna commenced a Phase 1/2 study to generate safety and immunogenicity data for an investigational pandemic influenza vaccine (mRNA-1018) candidate against the H5 and H7 avian ...
Spearheaded by National Economic Council Director Kevin Hassett and USDA Secretary Brooke Rollins, the plan prioritizes ...
The U.S. Department of Agriculture on Friday granted animal vaccine company Zoetis a conditional license to use an updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results